| abstract |
The present disclosure relates to isolated binding molecules that bind to human 4-1BB, nucleic acid molecules encoding the amino acid sequences of the binding molecules, vectors comprising the nucleic acid molecules, host cells containing the vectors, A pharmaceutical composition containing the binding molecule, and a method of using the binding molecule or composition. |